Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Aclarion Inc (ACON)

Aclarion Inc (ACON)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 703
  • Shares Outstanding, K 509
  • Annual Sales, $ 80 K
  • Annual Income, $ -4,910 K
  • EBIT $ -5 M
  • EBITDA $ -4 M
  • 60-Month Beta 0.47
  • Price/Sales 0.43
  • Price/Cash Flow N/A
  • Price/Book 0.02

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate -50.00
  • Number of Estimates 1
  • High Estimate -50.00
  • Low Estimate -50.00
  • Prior Year N/A
  • Growth Rate Est. (year over year) -105.01%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.0500 +13.33%
on 03/06/25
8.5000 -86.00%
on 03/03/25
-3.4800 (-74.52%)
since 02/10/25
3-Month
1.0500 +13.33%
on 03/06/25
129.6115 -99.08%
on 01/03/25
-59.1100 (-98.03%)
since 12/10/24
52-Week
1.0500 +13.33%
on 03/06/25
231.1500 -99.49%
on 04/25/24
-112.2075 (-98.95%)
since 03/08/24

Most Recent Stories

More News
Artificial Intelligence Influence on Healthcare Industry Reaching All Time Highs for Diagnostics and Treatments

TDOC : 8.93 (-2.40%)
AVAI : 0.3543 (+18.10%)
MDT : 93.80 (-0.74%)
TEM : 45.17 (-8.00%)
ACON : 1.1900 (-13.77%)
Artificial Intelligence Influence on Healthcare Industry Reaching All Time Highs for Diagnostics and Treatments

EQNX::TICKER_START (OTCQB:AVAI),(NASDAQ:TEM),(NYSE:TDOC),(NASDAQ:ACON),(NYSE:MDT) EQNX::TICKER_END

AVAI : 0.3543 (+18.10%)
TDOC : 8.93 (-2.40%)
MDT : 93.80 (-0.74%)
TEM : 45.17 (-8.00%)
ACON : 1.1900 (-13.77%)
Aclarion Announces Expansion Plans with RadNet Affiliates in New York and New Jersey

ACONW : 0.0622 (-7.44%)
ACON : 1.1900 (-13.77%)
Is Aclarion's Tie-Up With Scripps Health A Lasting Catalyst? Most Retail Traders Think It's A 'Game-Changer'

The company's follower count on Stocktwits jumped nearly 20%, while message volume surged by over 6,000% by the end of Monday's session.

VXF : 172.68 (-3.50%)
ACON : 1.1900 (-13.77%)
Aclarion Announces First Commercial Agreement with Scripps Health

ACONW : 0.0622 (-7.44%)
ACON : 1.1900 (-13.77%)
Aclarion, Inc. Announces Adjournment of Special Meeting of Stockholders

ACONW : 0.0622 (-7.44%)
ACON : 1.1900 (-13.77%)
Aclarion to Showcase Groundbreaking NOCISCAN Technology at the 2025 Spine Summit

ACONW : 0.0622 (-7.44%)
ACON : 1.1900 (-13.77%)
Aclarion Receives US Patent to Protect Expanded Applications of Magnetic Resonance Spectroscopy (MRS) Data Processing to Identify Pain and Infection Biomarkers Throughout the Body

ACONW : 0.0622 (-7.44%)
ACON : 1.1900 (-13.77%)
Aclarion Announces Northwestern Medicine as First CLARITY Trial Site

ACONW : 0.0622 (-7.44%)
ACON : 1.1900 (-13.77%)
Aclarion Announces CLARITY Trial for Nociscan Now Fully Funded

ACON : 1.1900 (-13.77%)

Business Summary

Aclarion Inc. is a healthcare technology company which leverages Magnetic Resonance Spectroscopy and a proprietary biomarker to optimize clinical treatments. The Company is also researching the application of AI and machine learning platforms to analyze both the raw spectroscopy data and the post-processed...

See More

Key Turning Points

3rd Resistance Point 1.5200
2nd Resistance Point 1.4500
1st Resistance Point 1.3200
Last Price 1.1900
1st Support Level 1.1200
2nd Support Level 1.0500
3rd Support Level 0.9200

See More

52-Week High 231.1500
Fibonacci 61.8% 143.2518
Fibonacci 50% 116.1000
Fibonacci 38.2% 88.9482
Last Price 1.1900
52-Week Low 1.0500

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar